Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma
Clinical trial NCT01360593 · COMPLETED
Trial details
- NCT number
- NCT01360593
- Sponsor
- David A. Clump, MD, PhD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-25
- Primary completion
- 2016-03-13
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.